title: [Expanded indication of National Health Insurance for H. pylori associated gastritis].
abstract: Since National Health Insurance covered eradication therapy for H. pylori infected gastritis, all patients with H. pylori infection could be received eradication under insurance. Cure of H. pylori infection improves histological gastritis, also atrophic change, and intestinal metaplasia. Prevention of H. pylori associated diseases such as gastric cancer is expected. According to Insurance instruction, it is carried out in order of endoscopic diagnosis of chronic gastritis, diagnosis of H. pylori infection, and eradication treatment. Endoscopic examination prior to H. pylori diagnosis is necessary for screening of gastric cancer. Endoscopic finding of RAC (regular arrangement of collecting venules) in the angle of stomach suggests lack of infection with H. pylori, disappearance of RAC suspects H. pylori infection.
authors.forename: Mototsugu
authors.initials: M
authors.lastname: Kato
mesh_terms: D000658:Amoxicillin / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D002908:Chronic Disease; D017291:Clarithromycin / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005756:Gastritis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology*; D005773:Gastroscopy; D016481:Helicobacter Infections; D016480:Helicobacter pylori; D006801:Humans; D007564:Japan; D064747:Lansoprazole / Q000008:administration & dosage; D008795:Metronidazole / Q000008:administration & dosage; D009313:National Health Programs / Q000639:trends; D054328:Proton Pump Inhibitors / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D013274:Stomach Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000900:Anti-Bacterial Agents; D054328:Proton Pump Inhibitors; D064747:Lansoprazole; D008795:Metronidazole; D000658:Amoxicillin; D017291:Clarithromycin